Finally, we demonstrate that Six1 expression correlates with phosphorylated ERK (pERK) levels in human breast cancers, suggesting that Six1 mediates its tumor promotional activities through activation of both TGF-β (previously shown) [12] and MEK/ERK signaling in the human context. Here, SIX1 is linked to breast carcinoma.